Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about NCOA2: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No AI portrait yet
| Gene Symbol | NCOA2 |
| Function | NCOA2 is a ~175 kDa protein containing multiple functional domains that mediate protein-protein interactions: |
| Primary Expression | both neurons and glial cells, with particular enrichment in pyramidal neurons and Purkinje cells [@ncoa2003] |
| Subcellular Localization | Primarily nuclear, consistent with its role as a transcriptional coactivator. |
| Molecular Weight | 175 kDa |
| Ensembl ID | ENSG00000140396 |
| GeneCards | NCOA2 |
| Human Protein Atlas | NCOA2 |
| N-terminal Domain | Contains basic helix-loop-helix (bHLH) and PAS (PER-ARNT-SIM) domains that mediate dimerization and DNA binding [@xu1999]. |
| C-terminal Activating Domains | Three autonomous activation domains (AD1, AD2, AD3) that recruit coactivators including histone acetyltransferases (CBP/p300), histone methyltransferases, and the Mediator complex [@leo2000]. |
| LXXLL Motifs | Seven LXXLL motifs that facilitate binding to nuclear receptor AF-2 domains in a ligand-dependent manner [@mckenna2002]. |
| Estrogen Receptors (ERα, ERβ) | Critical for neuroprotection, mitochondrial function, and cognitive function [@brinton2008]. |
| Glucocorticoid Receptor (GR) | Regulates stress response and neuronal viability [@sapolsky1996]. |
| Thyroid Hormone Receptors (TRα, TRβ) | Essential for brain development and myelin maintenance [@bernal2000]. |
| Retinoid X Receptors (RXR) | Partners in nuclear receptor heterodimers that regulate gene networks involved in neuronal survival [@mangelsdorf1995]. |
| Associated Diseases | neurodegeneration |
| Databases | GeneCardsUniProtNCBI GeneHPASTRING |
Knowledge base pages for this entity
graph TD
NCOA2["NCOA2"]
neurodegeneration["neurodegeneration"]
NCOA2 -->|"implicated_in"| neurodegeneration
style NCOA2 fill:#4a1a6b,stroke:#4fc3f7,stroke-width:2px,color:#e0e0e0| Target | Relation | Type | Str |
|---|---|---|---|
| No outgoing edges | |||
| Source | Relation | Type | Str |
|---|---|---|---|
| No incoming edges | |||
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
No debates reference this entity
Hypotheses and analyses mentioning NCOA2 in their description or question text
No additional research found